Jan 1, 2023 · Template Doping Control Form (DCF) that Anti-Doping Organizations (ADOs) can use for sample collection. Available in 1 language.

Dec 13, 2023 · The below documentation package includes a series of checklists, templates and FAQ that support the current International Standard for Testing and Investigations (ISTI) Guidelines. More resources can be found on ADEL through the Code Implementation Support Program (CISP). Available in 2 languages.

• A signed statement by the Laboratory Director or authorized delegate certifying that the Laboratory Documentation Package contains authentic copies of original data and forms; 2 Including split portions of the “B”

In the context of the cooperation in the fight against doping in sport, companies can use this template to undertake a review of project compounds (from candidate selection onward) to assess potential for risk for doping potential.

www.wada-ama.org OFFICIAL STATEMENT FROM WADA ON THE VRIJMAN REPORT Background WADA is effectively, the world watchdog for all matters related to anti-doping. WADA was formed in 1999 and, pursuant to its mandate delivered by its governance, 50 percent of whom come from the Sports Movement and 50

To ensure harmonized, coordinated and effective anti-doping programs at the international and national level with regard to detection, deterrence and prevention of doping.

The 2025 Prohibited List is one of the eight International Standards that are mandatory for all Signatories of the World Anti-Doping Code (Code). It designates what substances and …

The World Anti-Doping Agency (WADA) Code is the framework, policies, standards & rules for the strongest anti-doping programs in sport.

This Technical Document (TD) and its annexes outline the requirements for the production of Laboratory Documentation Packages by Laboratories and ABP Laboratories, as applicable.

Dear Colleagues, Today, the World Anti-Doping Agency (WADA) publishes an updated template of the Therapeutic Use Exemption (TUE) Application Form to support Anti-Doping Organizations (ADOs) in their implementation of the 2021 International Standard for Therapeutic Use Exemptions (ISTUE) , which comes into force on 1 January 2021.